scholarly journals A window of opportunity study of nivolumab in early-stage endometrial cancer patients with MMRd who had failure after progestins for fertility-sparing treatment (NIVEC)

2021 ◽  
Author(s):  
Young Hwa Kwak ◽  
Junsik Park ◽  
Yun-Jung Go ◽  
Sunghoon Kim ◽  
Jung-Yun Lee
Keyword(s):  
Endometrial Cancer ◽  
Cancer Patients ◽  
Early Stage ◽  
Window Of Opportunity ◽  
Fertility Sparing ◽  
Early Stage Endometrial Cancer

A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer

2012 ◽  
Vol 119 (3) ◽  
pp. 270-273 ◽  
Author(s):  
Polat Dursun ◽  
Serkan Erkanli ◽  
Ahmet Bariş Güzel ◽  
Murat Gultekin ◽  
Nefise Cagla Tarhan ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Early Stage ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Fertility Sparing ◽  
Early Stage Endometrial Cancer

Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients

2015 ◽  
Vol 11 (4) ◽  
pp. 607-615
Author(s):  
Faina Linkov ◽  
Robert P Edwards ◽  
Andrew Althouse ◽  
Jose A Rauh-Hain ◽  
Marcela G Del Carmen ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Early Stage ◽  
Survival Outcomes ◽  
Early Stage Endometrial Cancer

scholarly journals CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence

2017 ◽  
Vol 30 (7) ◽  
pp. 1032-1041 ◽  
Author(s):  
Katherine C Kurnit ◽  
Grace N Kim ◽  
Bryan M Fellman ◽  
Diana L Urbauer ◽  
Gordon B Mills ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Patients ◽  
Early Stage ◽  
Low Grade ◽  
Beta Catenin ◽  
Risk Of Recurrence ◽  
Increased Risk ◽  
Early Stage Endometrial Cancer
Sign in / Sign up

Export Citation Format

Share Document